| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/29/1999 | WO1999037315A1 Chemical derivatives of autoantigens and autoimmune-suppressive peptides and pharmaceutical composition containing the same |
| 07/29/1999 | WO1999037299A1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer |
| 07/29/1999 | WO1999037142A1 Method for producing transgenic animals |
| 07/29/1999 | WO1999031227A3 NOVEL PEPTIDE, apoEp1.B, COMPOSITIONS AND USES THEREOF |
| 07/29/1999 | WO1999031131A3 Mammalian calcitonin-like polypeptide-1 |
| 07/29/1999 | WO1999028340A3 Cruciform binding protein |
| 07/29/1999 | WO1999025862A3 Chimeric viral packaging signal without gag gene sequences |
| 07/29/1999 | WO1999025825A3 EXTENDED cDNAs FOR SECRETED PROTEINS |
| 07/29/1999 | WO1999020755A3 Novel cytokine receptors |
| 07/29/1999 | WO1999019506A3 Method for identifying binding ligands to receptors |
| 07/29/1999 | WO1999019476A3 NON-MAMMALIAN MESODERM INDUCTION EARLY RESPONSE (nm-MIER) GENE FAMILY |
| 07/29/1999 | WO1999019348A9 Laminins and uses thereof |
| 07/29/1999 | WO1999018204A3 HUMAN PROTEINS HAVING SECRETORY SIGNAL SEQUENCES AND cDNAS ENCODING THESE PROTEINS |
| 07/29/1999 | WO1999012968A3 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response |
| 07/29/1999 | WO1998059063A3 Bovine adenovirus type 3 genome |
| 07/29/1999 | WO1995030750A8 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 07/29/1999 | DE19802792A1 Inhibiting DNA modulation caused by p53 mutant, useful for treatment of cancer |
| 07/29/1999 | CA2320624A1 Mutants of il-16, processes for their production, and their use |
| 07/29/1999 | CA2319210A1 Cubilin protein, dna sequences encoding cubilin and uses thereof |
| 07/29/1999 | CA2319209A1 Promoter and regulator sequences ha ds10 g1: a gene lea of sunflower exclusively expressed in seeds since the maturation phase. |
| 07/29/1999 | CA2319208A1 Orphan receptors |
| 07/29/1999 | CA2319207A1 Peptides with .beta.1 integrin subunit dependent cell adhesion modulating activity |
| 07/29/1999 | CA2319141A1 Porcine reproductive and respiratory syndrome oral vaccine production in plants |
| 07/29/1999 | CA2319121A1 Use of inhibitors for the treatment of rtk-hyperfunction-induced disorders, particularly cancer |
| 07/29/1999 | CA2319118A1 Frozen food product |
| 07/29/1999 | CA2319115A1 Methods for identifying antimicrobial peptides that interact with enoyl acp reductase |
| 07/29/1999 | CA2319113A1 Biologically active hemagglutinin from type a clostridium botulinum and methods of use |
| 07/29/1999 | CA2319109A1 Meth1 and meth2 polynucleotides and polypeptides |
| 07/29/1999 | CA2319076A1 Expression of the insl4 gene in human embryonic bone tissues and applications |
| 07/29/1999 | CA2318979A1 Antigen-specific cells, methods of generating these cells and uses thereof |
| 07/29/1999 | CA2318935A1 Phagocytosis genes and uses thereof |
| 07/29/1999 | CA2318869A1 Antifreeze protein |
| 07/29/1999 | CA2318816A1 Ligand receptors and uses therefor |
| 07/29/1999 | CA2318743A1 Novel molecules of the tnf receptor superfamily and uses therefor |
| 07/29/1999 | CA2318727A1 Spoil protein and nucleic acid molecules and uses therefor |
| 07/29/1999 | CA2318574A1 Dna replication proteins of gram positive bacteria and their use to screen for chemical inhibitors |
| 07/29/1999 | CA2318440A1 Purification of fibrinogen |
| 07/29/1999 | CA2318352A1 Diagnosis and treatment of aur1 and/or aur2 related disorders |
| 07/29/1999 | CA2318313A1 Inhibition of dna modulation caused by mutated p53 |
| 07/29/1999 | CA2318303A1 Secreted proteins and polynucleotides encoding them |
| 07/29/1999 | CA2317704A1 Assessing risk for integrin antagonist/agonist mediated diseases |
| 07/29/1999 | CA2317492A1 Isolated, polypeptides which bind to hla-a29 molecules, nucleic acid, the molecules encoding these, and uses thereof |
| 07/29/1999 | CA2314677A1 Asthma related genes |
| 07/28/1999 | EP0931836A1 Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof |
| 07/28/1999 | EP0931834A2 Echinocandin binding domain of 1,3-Beta-glucan synthase |
| 07/28/1999 | EP0931832A1 Metalocarboxypeptidase inhibitors and derived molecules used as antitumor agents |
| 07/28/1999 | EP0931551A1 Diagnostics and therapeutics for transmissible spongiform encephalopathy and method for the manufacture of non-infective blood products and tissue derived products |
| 07/28/1999 | EP0931262A1 Biochemical markers of the human endometrium |
| 07/28/1999 | EP0931162A1 Production of a multimeric protein by cell fusion method |
| 07/28/1999 | EP0931159A2 Non-mammalian dna virus having an altered coat protein |
| 07/28/1999 | EP0931156A2 Gene expression and delivery systems and uses |
| 07/28/1999 | EP0931152A2 Crystal structures of a protein tyrosine kinase |
| 07/28/1999 | EP0931149A2 A novel haemopoietin receptor and genetic sequences encoding same |
| 07/28/1999 | EP0931148A1 Fibroblast growth factor homologs |
| 07/28/1999 | EP0931146A1 Rdgb-proteins |
| 07/28/1999 | EP0931145A1 Ptx sensitive g proteins, the production and use thereof |
| 07/28/1999 | EP0931144A1 Novel human phospholemman-like protein |
| 07/28/1999 | EP0931143A1 Production of recombinant peptide by transgenic fish |
| 07/28/1999 | EP0931096A2 HT m4?, METHODS OF TREATMENT AND ASSAYS, AGONISTS AND ANTAGONISTS |
| 07/28/1999 | EP0931095A2 Novel human lim proteins |
| 07/28/1999 | EP0931094A1 Methods for determining the presence of brain protein s-100 |
| 07/28/1999 | EP0931093A1 Helicobacter pylori live vaccine |
| 07/28/1999 | EP0931092A2 Variants of vascular endothelial cell growth factor having antagonistic properties |
| 07/28/1999 | EP0930894A1 Induction of rev and tat specific cytotoxic t-cells for prevention and treatment of human immunodeficiency virus (hiv) infection |
| 07/28/1999 | EP0879283A4 Glutenin genes and their uses |
| 07/28/1999 | EP0874639A4 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 07/28/1999 | EP0832133A4 Monoclonal antibody detection of proteins on sperm related to fertility |
| 07/28/1999 | EP0743958A4 Non-viral vector |
| 07/28/1999 | EP0698093B1 VON HIPPEL-LINDAU (VHL) DISEASE GENE AND CORRESPONDING cDNA AND METHODS FOR DETECTING CARRIERS OF THE VHL DISEASE GENE |
| 07/28/1999 | EP0678122B1 Recombinant anti-vla4 antibody molecules |
| 07/28/1999 | EP0621902B1 Dna structure-specific recognition protein and uses therefor |
| 07/28/1999 | EP0546119B1 Cell density signal molecule isolated from embryonic tendon cells |
| 07/28/1999 | EP0538401B1 Novel receptor-type phosphotyrosine phosphatase |
| 07/28/1999 | EP0131623B2 Chimeric genes suitable for expression in plant cells |
| 07/28/1999 | CN1224464A Growth factor and genetic sequence encoding same |
| 07/28/1999 | CN1224359A Lactoferrtin variants and uses thereof |
| 07/27/1999 | USRE36259 Treating with sodium caprylate and ethanol, diafiltering |
| 07/27/1999 | US5929307 Method for the production of hybrid plants |
| 07/27/1999 | US5929305 Genes which promote cold temperature and dehydration tolerance in plants |
| 07/27/1999 | US5929303 Fruit-specific and ripening-regulation expansin genes to control fruit texture and softening |
| 07/27/1999 | US5929302 Plant transformed with chimeric gene conferring fungal resistance |
| 07/27/1999 | US5929225 Human gene homologous to bacterial gene controlling sensitivity to methyl methane sulfonate; anticarcinogenic agents; for repairing alkylated nucleic acids; for treating cell death; antagonists to prevent tumor nucleic acid repair |
| 07/27/1999 | US5929224 Dna encoding human white blood cell activating proteins; useful in diagnosis as anticarcinogenic agents |
| 07/27/1999 | US5929223 Nucleotide sequence of drosophila cyclic 3',5'-adenosine monophosphate responsive transcriptional activator and antagonist |
| 07/27/1999 | US5929222 Expression of a foamy virus envelope protein |
| 07/27/1999 | US5929221 Pure culture of l-glutamic acid-producing coryneform bacterium having mutant nucleotide sequence which codes for deactivated surfactant resistance protein; for increased production of l-glutamic acid |
| 07/27/1999 | US5929220 Hepadnavirus receptor |
| 07/27/1999 | US5929213 Antibodies to growth differentiation factor-12 |
| 07/27/1999 | US5929212 CD3 specific recombinant antibody |
| 07/27/1999 | US5929211 Carbohydrate-directed cross-linking reagents |
| 07/27/1999 | US5929210 Purified polypeptide of irreversible, extracellular serine protease inhibitor; for diagnosis/treatment of related diseases; antitumor agents; cushing's/alzheimer's/parkinson's diseases; dwarfism; eating disorders |
| 07/27/1999 | US5929209 Somatostatin receptor protein |
| 07/27/1999 | US5929207 Polypeptide modulator of signal transduction proteins |
| 07/27/1999 | US5929041 Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor(GDNF) protein product |
| 07/27/1999 | US5929040 Method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 07/27/1999 | US5929036 Ligand or GMP-140 selectin and methods of use thereof |
| 07/27/1999 | US5929032 Method for treating Schwann and colon cells in vitro |
| 07/27/1999 | US5929031 Storage stable hemoglobin solutions |
| 07/27/1999 | US5929029 Human calcium-binding phosphoprotein |
| 07/27/1999 | US5928958 Superparamagnetic particles, process for their manufacture and usage |